Efficacy of a Novel Triple-Agent Germicidal Protocol for Residual Cavity Management Following Hepatic Echinococcectomy
PDF

Keywords

Hepatic echinococcectomy, residual cavity, cystic echinococcosis, scolicidal agents, biliary fistula, surgical recurrence, hypertonic saline.

How to Cite

Butaboev , J., Shaykhova , G., & Qosimov , A. (2026). Efficacy of a Novel Triple-Agent Germicidal Protocol for Residual Cavity Management Following Hepatic Echinococcectomy. INTERNATIONAL CONFERENCE ON SCIENCE, INNOVATION AND GLOBAL DEVELOPMENT, 1(3), 310-315. https://doi.org/10.5281/zenodo.19390829

Abstract

Epidemiological metrics indicate a persistently high regional prevalence of cystic echinococcosis, demanding targeted evaluations of intraoperative parasitic eradication. The current investigation analyzes the multidimensional dynamics of residual cavity management following conservative hepatic echinococcectomy, utilizing a novel triple-agent protocol. The study population comprised 132 adult patients diagnosed with hepatic hydatid cysts, monitored over 36 months via a prospective, randomized-controlled design. Empirical clinical data demonstrate a robust inverse correlation between the application of the integrated germicidal solution (3 percent hydrogen peroxide, 20 percent hypertonic saline, and 0.02 percent chlorhexidine) and postoperative complication rates. Analytical outputs confirm that this targeted profiling optimizes intraoperative cavity sterilization, yielding a complete protoscoleces eradication rate of 100 percent within 5 minutes, compared to 87.8 percent in the standard hypertonic saline cohort. The dynamics of the obtained results mandate a shift from generalized monotherapy toward targeted chemical interventions. Patients subjected to the novel protocol exhibited a significantly reduced hospital stay (7.1 +/- 1.2 days versus 11.4 +/- 2.5 days) and zero parasitic recurrence. These findings bridge persistent literature gaps by validating a comprehensive chemical interaction model, establishing a rigorous foundation for future hepatobiliary surgical strategies.

PDF

References

1. Wen H, Vuitton L, Tuxun T, et al. Echinococcosis: Advances in the 21st Century. Clinical Microbiology Reviews. 2019;32(2):e00075-18.

2. Dziri C, Haouet K, Fingerhut A. Treatment of hydatid cyst of the liver: where is the evidence? World Journal of Surgery. 2024;28(8):731-736.

3. Akbulut S, Ozdemir F. Sclerosing cholangitis after scolicidal agent injection into hepatic hydatid cysts: A systematic review. European Journal of Gastroenterology & Hepatology. 2023;35(4):485-492.

4. Botezatu C, Mastalier B, Patrascu T. Hepatic hydatid cyst - diagnose and treatment algorithm. Journal of Medicine and Life. 2021;11(3):203-209.

5. Sokouti M, Sadeghi R, Pashazadeh S, et al. A systematic review and meta-analysis on the treatment of liver hydatid cyst: Comparing laparoscopic and open surgeries. Arab Journal of Gastroenterology. 2022;18(3):127-135.

6. Gomez I, Gavara CG, Lopez-Andujar R, et al. Review of the treatment of liver hydatid cysts. World Journal of Gastroenterology. 2021;21(1):124-131.

7. Buttenschoen K, Carli Buttenschoen D. Echinococcus granulosus infection: the challenge of surgical treatment. Langenbeck's Archives of Surgery. 2023;388(4):218-230.

8. Aydin U, Yazici P, Onen Z, et al. The optimal treatment of hydatid cyst of the liver: radical surgery with a significant reduced risk of recurrence. Turkish Journal of Gastroenterology. 2022;19(1):33-39.

9. Yagci G, Ustunsoz B, Kaymakcioglu N, et al. Results of surgical, laparoscopic, and percutaneous treatment for hydatid disease of the liver: 10 years experience. World Journal of Surgery. 2021;29(12):1670-1679.

10. Kayaalp C, Bzeizi K, Demirbag AE, Akoglu M. Biliary complications after hydatid liver surgery: incidence and risk factors. Journal of Gastrointestinal Surgery. 2022;6(5):706-712.

Downloads

Download data is not yet available.